Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Gastric Cancer | Research

Analysis of the short- and long-term outcomes of membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for treating advanced proximal gastric cancer

Authors: Yanchang Xu, Zhixiong Li, Guofeng Pan, Haiyan Wu, Wenlin Lin, Jian Chen, Junpeng Li

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Objective

To investigate the short- and long-term efficacy of membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for the treatment of advanced proximal gastric cancer.

Methods

A retrospective analysis was conducted in 186 patients with advanced proximal gastric cancer who underwent mesenteric anatomy-guided laparoscopic spleen-preserving splenic hilar lymph node dissection for advanced proximal gastric cancer in our center from March 2013 to March 2018. The patients were divided into two groups: one group was the laparoscopic anterior splenic hilar lymph node dissection group which we named L-ASHD, n = 103), while the other group was the laparoscopic circumferential splenic hilar lymph node dissection group which we named L-CSHD, n = 83).

Results

There was no significant difference in total operative time, intraoperative blood loss, postoperative length of hospital stay, and incidence of postoperative complications, etc. (P > 0.05). The number of harvested splenic hilar lymph nodes and the number of patients with harvested positive splenic hilar lymph nodes were both higher in the L-CSHD than in the L-ASHD (3.90 ± 2.52 vs. 3.02 ± 3.07, P < 0.05; 19 vs. 9 patients, P < 0.05). The positive rate of lymph nodes behind the splenic hilar was 8.4%. Kaplan–Meier survival curves showed that patients in the L-CSHD had similar OS and DFS compared with those of patients in the L-ASHD.

Conclusion

Membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for advanced proximal gastric cancer is safe and feasible and can help avoid the incomplete dissection of positive lymph nodes.
Literature
1.
go back to reference Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef
2.
go back to reference Monig SP, Collet PH, Baldus SE, et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76(2):89 02.CrossRef Monig SP, Collet PH, Baldus SE, et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76(2):89 02.CrossRef
3.
go back to reference Xiang H. 14th edition of Japan “Gastric Cancer Treatment Protocol”: important changes. Chin J Pract Surg. 2010;30(04):241–6. Xiang H. 14th edition of Japan “Gastric Cancer Treatment Protocol”: important changes. Chin J Pract Surg. 2010;30(04):241–6.
4.
go back to reference Goh PM, Khan AZ, So JB, et al. Early experience with laparoscopic radical gastrectomy for advanced gastric cancer. Surg Laparosc Endosc Percutan Tech. 2001;11:83–7.PubMed Goh PM, Khan AZ, So JB, et al. Early experience with laparoscopic radical gastrectomy for advanced gastric cancer. Surg Laparosc Endosc Percutan Tech. 2001;11:83–7.PubMed
5.
go back to reference Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Brit J Cancer. 2004;90(9):1727–32.CrossRef Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Brit J Cancer. 2004;90(9):1727–32.CrossRef
6.
go back to reference Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol. 2009;135(1):29–38.CrossRef Menges M, Hoehler T. Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol. 2009;135(1):29–38.CrossRef
7.
go back to reference Xie D, Osaiweran H, Liu L, et al. Mesogastrium: a fifth route of metastasis in gastric cancer? Med Hypotheses. 2013;80:498–500.CrossRef Xie D, Osaiweran H, Liu L, et al. Mesogastrium: a fifth route of metastasis in gastric cancer? Med Hypotheses. 2013;80:498–500.CrossRef
8.
go back to reference Gong JP. The fifth metastasis route of gastric cancer and the third principle of radical operation. Chin J Gastrointestinal Surg. 2013;16:109–10. Gong JP. The fifth metastasis route of gastric cancer and the third principle of radical operation. Chin J Gastrointestinal Surg. 2013;16:109–10.
9.
go back to reference Chikara K, Hiroshi S, Masato N, et al. Association of the number of metastatic perigastric lymph nodes with long-term survival in gastric cancer. Hepatogastroenterology. 2005;52(61):277–80.PubMed Chikara K, Hiroshi S, Masato N, et al. Association of the number of metastatic perigastric lymph nodes with long-term survival in gastric cancer. Hepatogastroenterology. 2005;52(61):277–80.PubMed
10.
go back to reference Zhu GL, Sun Z, Wang ZN, et al. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach. J Surg Oncol. 2012;105(8):786–92.CrossRef Zhu GL, Sun Z, Wang ZN, et al. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach. J Surg Oncol. 2012;105(8):786–92.CrossRef
11.
go back to reference Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y. Postoperative morbidity/mortality and survival rates after total gastrectomy with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Hepatogastroenterology. 2004;51(55):298–302.PubMed Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y. Postoperative morbidity/mortality and survival rates after total gastrectomy with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Hepatogastroenterology. 2004;51(55):298–302.PubMed
12.
go back to reference Wang JY, Huang TJ, Chen FM, Huang CJ, Huang YS, Hsieh JS. A comparative study of pancreatectomy and pancreas-preserving gastrectomy in advanced gastric carcinoma. Hepatogastroenterology. 2004;51(58):1229–32.PubMed Wang JY, Huang TJ, Chen FM, Huang CJ, Huang YS, Hsieh JS. A comparative study of pancreatectomy and pancreas-preserving gastrectomy in advanced gastric carcinoma. Hepatogastroenterology. 2004;51(58):1229–32.PubMed
13.
go back to reference Hyung WJ, Lim JS, Song J, et al. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg. 2008;207:e6–11.CrossRef Hyung WJ, Lim JS, Song J, et al. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg. 2008;207:e6–11.CrossRef
14.
go back to reference Okabe H, Obama K, Kan T, et al. Medial approach for laparoscopic total gastrectomy with splenic lymph node dissection. J Am Coll Surg. 2010;211(1):e1–6.CrossRef Okabe H, Obama K, Kan T, et al. Medial approach for laparoscopic total gastrectomy with splenic lymph node dissection. J Am Coll Surg. 2010;211(1):e1–6.CrossRef
15.
go back to reference Huang CM, Chen QY, Lin JX, et al. Huang’s three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. Chin J Cancer Res. 2014;26(2):208–10.PubMedPubMedCentral Huang CM, Chen QY, Lin JX, et al. Huang’s three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. Chin J Cancer Res. 2014;26(2):208–10.PubMedPubMedCentral
16.
go back to reference Son SY, Shin DJ, Park YS, et al. Spleen-preserving lymphadenectomy versus splenectomy in laparoscopic total gastrectomy for advanced gastric cancer. Surg Oncol. 2017;26(2):207–11.CrossRef Son SY, Shin DJ, Park YS, et al. Spleen-preserving lymphadenectomy versus splenectomy in laparoscopic total gastrectomy for advanced gastric cancer. Surg Oncol. 2017;26(2):207–11.CrossRef
17.
go back to reference Huang CM, Chen T, Lin JX, et al. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study. Surg Endosc. 2017;31(3):1383–92.CrossRef Huang CM, Chen T, Lin JX, et al. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study. Surg Endosc. 2017;31(3):1383–92.CrossRef
Metadata
Title
Analysis of the short- and long-term outcomes of membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for treating advanced proximal gastric cancer
Authors
Yanchang Xu
Zhixiong Li
Guofeng Pan
Haiyan Wu
Wenlin Lin
Jian Chen
Junpeng Li
Publication date
01-12-2019
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1610-z

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue